Lahmer Tobias, Messer Marlena, Ehmer Ursula, Eser Stefan, Beitz Analena, Fekecs Lisa, Schmid Roland M, Huber Wolfgang
II. Medizinische Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Str. 22, 81675, Munich, Germany.
Mycopathologia. 2016 Apr;181(3-4):267-71. doi: 10.1007/s11046-015-9952-8. Epub 2015 Oct 11.
Pseudallescheria boydii is a fungal organism known to affect immunocompromised patients. This organism is known to cause, in severe cases, invasive infection of various organs such as the central nervous, cardiovascular, and respiratory systems. We report an unusual case of pulmonary P. boydii pneumonia in an immunocompromised critically ill patient with a co-infection of Aspergillus fumigatus and Aspergillus terreus with ARDS. This case highlights the importance of a high index of suspicion for superimposed fungal infections in patients who are critically ill and immunocompromised. Uncommon fungal pathogens should be considered in the differential diagnosis of respiratory failure, especially if diagnostic markers such as galactomannan (from BAL and serum) or 1,3-beta-D-glucan are elevated. Further diagnostic interventions are warranted when insufficient clinical improvement is observed to prevent treatment failure and adverse outcomes.
波氏假阿利什霉是一种已知会感染免疫功能低下患者的真菌。这种真菌在严重情况下会导致侵袭性感染各种器官,如中枢神经、心血管和呼吸系统。我们报告了一例免疫功能低下的重症患者发生肺部波氏假阿利什霉肺炎的罕见病例,该患者同时感染了烟曲霉和土曲霉并伴有急性呼吸窘迫综合征(ARDS)。该病例强调了对重症且免疫功能低下患者发生叠加真菌感染保持高度怀疑的重要性。在呼吸衰竭的鉴别诊断中应考虑罕见的真菌病原体,特别是当半乳甘露聚糖(来自支气管肺泡灌洗和血清)或1,3-β-D-葡聚糖等诊断标志物升高时。当观察到临床改善不足时,有必要采取进一步的诊断干预措施,以防止治疗失败和不良后果。